Pascal Gunsch

Pascal Gunsch is a Researcher in the Radiotherapy department at Erasmus University Medical Center (Erasmus MC), Rotterdam, Netherlands, affiliated with Erasmus University Rotterdam. His work centers on optimizing radiation therapy protocols to address treatment complications in oncology.

His research focuses on combating radiation-induced immunosuppression in head and neck squamous cell carcinoma through innovative radiotherapy techniques. Key interests include proton therapy, hypofractionated dose regimens, and the intersection of radiation biology with immunosuppressive treatments, aiming to preserve immune function during cancer therapy.

Recent publications demonstrate a clear trend toward integrating advanced radiotherapy modalities (protons and photons) with immunological considerations. The HYDRA trial protocol exemplifies this shift toward personalized, immune-preserving radiation oncology approaches that prioritize patient immune resilience alongside tumor control.